Differences

This shows you the differences between two versions of the page.

--- publications [2023/09/11 09:42]
ramirez [2022]
+++ publications [2024/04/13 17:31]
ramirez [2024]
@@ Line 1: / Line 1: @@
 ====== Publications ======
+===== 2024  =====
+Faria NA, Touret T, Simões AS, Palos C, Bispo S, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], Carriço J, Pinto M, Toscano C, Gonçalves E, Gonçalves ML, Costa A, Araújo M, Duarte A, de Lencastre H, Serrano M, Sá-Leão R, Miragaia M. 2024. <fc #0000FF>Genomic Insights into the expansion of carbapenem-resistant //Klebsiella pneumoniae// within Portuguese Hospitals</fc>. J Hosp Infect S0195-6701(24)00106–3. [[https://www.ncbi.nlm.nih.gov/pubmed/38554808/|(PMID: 38554808)]]
+Xie O, Morris JM, Hayes AJ, Towers RJ, Jespersen MG, Lees JA, Ben Zakour NL, Berking O, Baines SL, Carter GP, Tonkin-Hill G, Schrieber L, McIntyre L, Lacey JA, James TB, Sriprakash KS, Beatson SA, Hasegawa T, Giffard P, Steer AC, Batzloff MR, Beall BW, [[people:mdpinho|Pinho MD]], [[people:ramirez|Ramirez M]], Bessen DE, Dougan G, Bentley SD, Walker MJ, Currie BJ, Tong SYC, McMillan DJ, Davies MR. 2024. <fc #0000FF>Inter-species gene flow drives ongoing evolution of Streptococcus pyogenes and //Streptococcus dysgalactiae// subsp. //equisimilis//</fc>. Nat Commun 15:2286. [[https://www.ncbi.nlm.nih.gov/pubmed/38480728/|(PMID: 38480728)]]
+Mendes Pedro D, Paulo SE, Santos CM, Fonseca AB, [[people:jmelocristino|Melo-Cristino J]], Pereira AA, Caneiras C. 2024. <fc #0000FF>Extensively drug-resistant //Pseudomonas aeruginosa//: clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care university hospital center in Portugal – A cross-sectional and retrospective observational study</fc>. Frontiers in Microbiology 15. //In press//
+Bajanca-Lavado MP, Pinto M, Carvalho MD, Jantarada Domingos G, [[people:jmelocristino|Melo-Cristino J]]. 2024. <fc #0000FF>Rare serotype c //Haemophilus influenzae// invasive isolate: characterization of the first case in Portugal</fc>. Eur J Clin Microbiol Infect Dis //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/38332396/|(PMID: 38332396)]]
+[[people:anacosta|Silva-Costa C]], [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M.]] 2024. <fc #0000FF>//Streptococcus pneumoniae//</fc>, p. 1479–1490. In Tang, Y-W, Hindiyeh, MY, Liu, D, Sails, A, Spearman, P, Zhang, J-R (eds.), Molecular Medical Microbiology (Third Edition). Academic Press. [[https://doi.org/10.1016/B978-0-12-818619-0.00095-2|doi:10.1016/B978-0-12-818619-0.00095-2]][[https://www.sciencedirect.com/science/article/abs/pii/B9780128186190000952
+|Publisher site]]
 ===== 2023  =====
+[[people:anacosta|Silva-Costa C]], Gomes-Silva J, Santos A, [[people:ramirez|Ramirez M]], [[people:jmelocristino|Melo-Cristino J]], The Portuguese Group for the Study of Streptococcal Infections. 2023. <fc #0000FF>Adult non-invasive pneumococcal pneumonia in Portugal is dominated by serotype 3 and non-PCV13 serotypes 3-years after near universal PCV13 use in children</fc>. Frontiers in Public Health 11:1279656 [[https://www.ncbi.nlm.nih.gov/pubmed/38186693/|(PMID: 38186693)]]
-Gouveia C, Bajanca-Lavado MP, Mamede R, Araújo Carvalho A, Rodrigues F, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M.]], [[people:afriaes|Friães A]], Portuguese Group for the Study of Streptococcal Infections,  Portuguese Study Group of Pediatric Invasive Streptococcal Disease. 2023. <fc #0000FF>Sustained increase of paediatric invasive //Streptococcus pyogenes// infections dominated by M1<sub>UK</sub> and diverse //emm//12 isolates, Portugal, September 2022 to May 2023.</fc> Eurosurveillance 28(36). [[http://www.ncbi.nlm.nih.gov/pubmed/37676143/|(PMID: 37676143)]]
+Mendes G, Santos ML, Ramalho JF, Bruschy-Fonseca A, Lito L, Mendes-Pedro D, Duarte A, [[people:jmelocristino|Melo-Cristino J]], Caneiras C. 2023. <fc #0000FF>Genomic characterisation of a novel KPC-98-producing clinical //Klebsiella pneumoniae// strain conferring resistance to ceftazidime/avibactam</fc>. Int J Antimicrob Agents 62:107013. [[https://www.ncbi.nlm.nih.gov/pubmed/37875180/|(PMID: 37875180)]]
+Grobusch MP, Ruiz Del Portal Luyten C, Visser BJ, de Jong HK, Goorhuis A, Hanscheid T. 2023. <fc #0000FF>Overcoming publication and dissemination bias in infectious diseases clinical trials</fc>. Lancet Infect Dis S1473-3099(23)00455–3. [[https://www.ncbi.nlm.nih.gov/pubmed/37837983/|(PMID: 37837983)]]
+Gouveia C, Bajanca-Lavado MP, Mamede R, Araújo Carvalho A, Rodrigues F, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M.]], [[people:afriaes|Friães A]], Portuguese Group for the Study of Streptococcal Infections,  Portuguese Study Group of Pediatric Invasive Streptococcal Disease. 2023. <fc #0000FF>Sustained increase of paediatric invasive //Streptococcus pyogenes// infections dominated by M1<sub>UK</sub> and diverse //emm//12 isolates, Portugal, September 2022 to May 2023.</fc> Eurosurveillance 28(36). [[https://www.ncbi.nlm.nih.gov/pubmed/37676143/|(PMID: 37676143)]]
+Xie O, Morris JM, Hayes AJ, Towers RJ, Jespersen MG, Lees JA, Zakour NLB, Berking O, Baines SL, Carter GP, Tonkin-Hill G, Schrieber L, McIntyre L, Lacey JA, James TB, Sriprakash KS, Beatson SA, Hasegawa T, Giffard P, Steer AC, Batzloff MR, Beall BW, [[people:mdpinho|Pinho MD]], [[people:ramirez|Ramirez M.]], Bessen DE, Dougan G, Bentley SD, Walker MJ, Currie BJ, Tong SYC, McMillan DJ, Davies MR. 2023. <fc #0000FF>Inter-species gene flow drives ongoing evolution of //Streptococcus pyogenes// and //Streptococcus dysgalactiae// subsp. //equisimilis//</fc>. bioRxiv [[https://doi.org/10.1101/2023.08.10.552873|(doi: 10.1101/2023.08.10.552873)]].
+Pinto Junior VL, Valadas E, Hanscheid T. 2023. <fc #0000FF>Combating vaccine hesitancy requires knowledge of misfortunes and controversies</fc>. Acta Med Port 36:537–540. [[https://pubmed.ncbi.nlm.nih.gov/37579748/|(PMID: 37579748)]]
 Riche CVW, Cassol R, Falci DR, [[people:ramirez|Ramirez M]], Dias CAG. 2023. <fc #0000FF>Epidemiology and risk factors for mortality among methicillin-resistant //Staphylococcus aureus// bacteremic patients in Southern Brazil</fc>. PLoS One 18:e0283774. [[https://pubmed.ncbi.nlm.nih.gov/37053222/|(PMID: 37053222)]]
-Bouchami O, Machado M, Carriço JA, [[people:jmelocristino|Melo-Cristino J]], de Lencastre H, Miragaia M. 2023. <fc #0000FF>Spontaneous genomic variation as a survival strategy of nosocomial //Staphylococcus haemolyticus//</fc>. Microbiol Spectr 11:e0255222. [[https://pubmed.ncbi.nlm.nih.gov/36877037/|(PMID: 36877037)]]
+Marinho PF, Vieira SL, Carvalho TG, Peleteiro MC, Hanscheid T. 2023. <fc #0000FF>A novel and simple heat-based method eliminates the highly detrimental effect of xylene deparaffinization on acid-fast stains</fc>. Am J Clin Pathol 160:81–88. [[https://pubmed.ncbi.nlm.nih.gov/36897250/|(PMID: 36897250)]]
+Bouchami O, Machado M, [[people:jcarrico|Carriço JA]], [[people:jmelocristino|Melo-Cristino J]], de Lencastre H, Miragaia M. 2023. <fc #0000FF>Spontaneous genomic variation as a survival strategy of nosocomial //Staphylococcus haemolyticus//</fc>. Microbiol Spectr 11:e0255222. [[https://pubmed.ncbi.nlm.nih.gov/36877037/|(PMID: 36877037)]]
+Marinho PF, Hanscheid T. 2023. <fc #0000FF>A simple heat-based alternative method for deparaffinization of histological sections significantly improves acid-fast staining results for Mycobacteria in tissue</fc>. MethodsX 10:102079. [[https://pubmed.ncbi.nlm.nih.gov/36865652/|(PMID: 36865652)]]
 Schnyder JL, de Jong HK, Bache EB, van Hest RM, Schlagenhauf P, Borrmann S, Hanscheid T, Grobusch MP. 2023. <fc #0000FF>On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives</fc>. Travel Med Infect Dis 52: //In press// [[https://pubmed.ncbi.nlm.nih.gov/36526126/|(PMID: 36526126)]]